Scienture Holdings Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
9
- Stock Symbol
-
SCNX
- Investments
-
9
- Share Price
-
$2.28
- (As of Friday Closing)
Scienture Holdings General Information
Description
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
Contact Information
Website
www.scientureholdings.comCorporate Office
- 2420 Brunello Trace
- Lutz, FL 34458
- United States
Corporate Office
- 2420 Brunello Trace
- Lutz, FL 34458
- United States
Scienture Holdings Stock Performance
As of 20-Nov-2026, Scienture Holdings’s stock price is $2.28. Its current market cap is $4.07M with 1.79M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.28 | $2.44 | $2.00 - $18.75 | $4.07M | 1.79M | 155K | -$51.74 |
Scienture Holdings Financials Summary
As of 30-Sep-2026, Scienture Holdings has a trailing 12-month revenue of $1.65M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 13,170 | 22,921 | 54,995 | 4,498 |
| Revenue | 1,655 | 432 | 137 | 1,364 |
| EBITDA | (39,497) | (39,235) | (17,525) | (6,294) |
| Net Income | (40,354) | (41,512) | 9,066 | (17,844) |
| Total Assets | 87,184 | 84,178 | 104,854 | 12,533 |
| Total Debt | 10,991 | 24 | 3,533 | 210 |
Scienture Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Scienture Holdings Comparisons
Industry
Financing
Details
Scienture Holdings Competitors (6)
One of Scienture Holdings’s 6 competitors is McKesson, a Corporation company based in Irving, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| McKesson | Corporation | Irving, TX | ||||
| Teladoc Health | Formerly VC-backed | New York, NY | ||||
| Cencora | Corporation | Conshohocken, PA | ||||
| Doctor On Demand | Private Equity-Backed | San Francisco, CA | ||||
| MDLive | Venture Capital-Backed | Miramar, FL |
Scienture Holdings Signals
Scienture Holdings Investments & Acquisitions (9)
Scienture Holdings’s most recent deal was a Reverse Merger with Scienture for . The deal was made on 25-Jul-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Scienture | 25-Jul-2024 | Reverse Merger | Drug Discovery | ||
| Superlatus | 31-Jul-2023 | Merger/Acquisition | Food Products | ||
| SoSRx | 15-Feb-2022 | Joint Venture | Internet Retail | ||
| Bonum Health | 23-Oct-2019 | Merger/Acquisition | Other Healthcare Technology Systems | ||
| SyncHealth | 17-Jan-2019 | Joint Venture | Vertical Market Software |
Scienture Holdings ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
24.1 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Distribution
Subindustry
of 42
Rank
Percentile
Scienture Holdings Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Superlatus | New York, NY | 2022 | |
| Scienture | New York, NY | 2019 | |
| Integra Pharma Solutions | Tampa, FL | 2010 |
Scienture Holdings FAQs
-
When was Scienture Holdings founded?
Scienture Holdings was founded in 2010.
-
Where is Scienture Holdings headquartered?
Scienture Holdings is headquartered in Lutz, FL.
-
What is the size of Scienture Holdings?
Scienture Holdings has 9 total employees.
-
What industry is Scienture Holdings in?
Scienture Holdings’s primary industry is Other Healthcare Technology Systems.
-
Is Scienture Holdings a private or public company?
Scienture Holdings is a Public company.
-
What is Scienture Holdings’s stock symbol?
The ticker symbol for Scienture Holdings is SCNX.
-
What is the current stock price of Scienture Holdings?
As of 20-Nov-2026 the stock price of Scienture Holdings is $2.28.
-
What is the current market cap of Scienture Holdings?
The current market capitalization of Scienture Holdings is $4.07M.
-
What is Scienture Holdings’s current revenue?
The trailing twelve month revenue for Scienture Holdings is $1.65M.
-
Who are Scienture Holdings’s competitors?
McKesson, Teladoc Health, Cencora, Doctor On Demand, and MDLive are some of the 6 competitors of Scienture Holdings.
-
What is Scienture Holdings’s annual earnings per share (EPS)?
Scienture Holdings’s EPS for 12 months was -$51.74.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process